Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Fennec Pharmaceuticals stock
Learn how to easily invest in Fennec Pharmaceuticals stock.
Fennec Pharmaceuticals Inc is a biotechnology business based in the US. Fennec Pharmaceuticals shares (FENC) are listed on the NASDAQ and all prices are listed in US Dollars. Fennec Pharmaceuticals employs 9 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Fennec Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FENC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Fennec Pharmaceuticals stock price (NASDAQ: FENC)Use our graph to track the performance of FENC stocks over time.
Fennec Pharmaceuticals shares at a glance
|Latest market close||$4.60|
|52-week range||$3.82 - $10.08|
|50-day moving average||$6.03|
|200-day moving average||$7.08|
|Wall St. target price||$10.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.63|
Buy Fennec Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Fennec Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Fennec Pharmaceuticals price performance over time
|1 week (2022-01-12)||-3.06%|
|1 month (2021-12-17)||12.75%|
|3 months (2021-10-19)||-48.26%|
|6 months (2021-07-19)||-29.66%|
|1 year (2021-01-19)||-41.85%|
|2 years (2020-01-17)||-25.57%|
|3 years (2019-01-18)||6.98|
|5 years (2017-01-19)||135.90%|
Fennec Pharmaceuticals financials
|Gross profit TTM||$170,000|
|Return on assets TTM||-34.04%|
|Return on equity TTM||-64.37%|
|Market capitalisation||$120.4 million|
TTM: trailing 12 months
Fennec Pharmaceuticals share dividends
We're not expecting Fennec Pharmaceuticals to pay a dividend over the next 12 months.
Have Fennec Pharmaceuticals's shares ever split?
Fennec Pharmaceuticals's shares were split on a 1:3 basis on 4 September 2014. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Fennec Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Fennec Pharmaceuticals shares which in turn could have impacted Fennec Pharmaceuticals's share price.
Fennec Pharmaceuticals share price volatility
Over the last 12 months, Fennec Pharmaceuticals's shares have ranged in value from as little as $3.822 up to $10.078. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fennec Pharmaceuticals's is 0.0588. This would suggest that Fennec Pharmaceuticals's shares are less volatile than average (for this exchange).
Fennec Pharmaceuticals overview
Fennec Pharmaceuticals Inc. , a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals in the news
Fennec Pharmaceuticals : Corporate Presentation January 2022
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questionsWhat percentage of Fennec Pharmaceuticals is owned by insiders or institutions?
Currently 16.942% of Fennec Pharmaceuticals shares are held by insiders and 44.821% by institutions. How many people work for Fennec Pharmaceuticals?
Latest data suggests 9 work at Fennec Pharmaceuticals. When does the fiscal year end for Fennec Pharmaceuticals?
Fennec Pharmaceuticals's fiscal year ends in December. Where is Fennec Pharmaceuticals based?
Fennec Pharmaceuticals's address is: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709 What is Fennec Pharmaceuticals's ISIN number?
Fennec Pharmaceuticals's international securities identification number is: CA31447P1009 What is Fennec Pharmaceuticals's CUSIP number?
Fennec Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00686R101
More guides on Finder
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
How to buy HeartCore Enterprises (HTCR) stock when it goes public
Everything we know about the HeartCore Enterprises IPO, plus information on how to buy in.
Ask an Expert